Researchers at the University of Birmingham have shown that it’s possible to produce a compound with anti-cancer properties directly from feverfew — a common flowering garden plant. The team was able to extract the compound from the flowers and modify it so it could be used to kill chronic lymphocytic cells in the laboratory. Feverfew is grown in many gardens, and also commonly sold in health food shops as a remedy for migraine and other aches and pains.
The compound the researchers were investigating is called parthenolide and was identified by scientists as having anti-cancer properties several years ago. Although available commercially, it is extremely expensive with poor “drug-like” properties and has not progressed beyond basic research.
Researchers were able to show a method not only for producing the parthenolide directly from plants, but a way of modifying it to produce a number of compounds that killed cancer cells in in vitro experiments. The particular properties of these compounds make them much more promising as drugs that could be used in the clinic.
The parthenolide compound appears to work by increasing the levels of reactive oxygen species (ROS) in cells. Cancer cells already have higher levels of these unstable molecules and so the effect of the parthenolide is to increase levels of these to a critical point, causing the cell to die.
The study, published in MedChemComm, was a multidisciplinary program, drawing together researchers from the University’s Institute of Cancer and Genomic Studies, the School of Chemistry and the drug discovery services companies, Sygnature Discovery and Apconix. The University of Birmingham’s Winterbourne Botanic Garden oversaw the cultivation of the plants in sufficient volume for the drug screen to take place.
Professor John Fossey, of the University’s School of Chemistry, says: “This research is important not only because we have shown a way of producing parthenolide that could make it much more accessible to researchers, but also because we’ve been able to improve its “drug-like” properties to kill cancer cells. It’s a clear demonstration that parthenolide has the potential to progress from the flowerbed into the clinic.”
Lee Hale, Head of Winterbourne Botanic Garden and Abigail Gulliver, Winterbourne’s Horticultural Adviser oversaw the cultivation and harvesting of the plants. Hale explains: “After trials on related plant species within the Asteraceae family it soon became apparent that Tanacetum parthenium — feverfew — provided the optimum levels of parthenolide.”
“Feverfew is a short lived perennial plant which we sowed on an annual basis for the trial to ensure continuity of supply. This was necessary as winter weather can result in plant losses,” adds Abigail Gulliver.
Materials provided by University of Birmingham. Note: Content may be edited for style and length. University of Birmingham. “Hidden chemistry in flowers shown to kill cancer cells.” ScienceDaily. ScienceDaily, 1 August 2019. www.sciencedaily.com/releases/2019/08/190801180929.htm.
HIFU is an FDA approved precise and targeted therapy that reduces the risk of complications caused by surgery and radiation. Focal Therapy is not associated with incontinence, and erectile dysfunction is just under 10%. Sparing of the urethra avoids scar tissue formation which, when present, may diminish the urinary stream. The eventual need for additional therapy is now under 10%.
Dr. Michael Lazar offers a HIFU Program in partnership with HIFU Prostate Services, LLC (HPS). HIFU Prostate Services, LLC (HPS) is a leading provider of minimally-invasive prostate cancer treatments using High Intensity Focused Ultrasound (HIFU). HIFU prostate treatments are available at San Francisco, Marin County, and Santa Rosa.
HIFU has many proven advantages over traditional treatment modalities for prostate disease. Call (707) 546-5553 to make an appointment with Dr. Lazar. Visit www.CaliforniaHIFU.com for more information. Fill out our online questionnaire to see if you qualify.